The four serotypes of dengue virus (DENV-1 to -4) represent the most prevalent mosquito-borne viral pathogens in humans. While there are several promising vaccine Nordihydroguaiaretic acid candidates in clinical trials approved vaccines or antivirals are not yet available. Here we describe the identification and characterization of a spiropyrazolopyridone as a novel inhibitor of DENV by… Continue reading The four serotypes of dengue virus (DENV-1 to -4) represent the